...company’s partnerships have generated $10 million to date. Two small deals in 2002 - with Cerylid Biosciences Ltd....

...prior deal, the institute is running preclinical studies on the company’s CBL 316 cancer compound. Cerylid Biosciences Ltd....

...companies partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...
...of natural compounds for hits against Anadys targets. Anadys Pharmaceuticals Inc. , San Diego, Calif. Cerylid Biosciences Ltd....

...Anadys (San Diego, Calif.) and Cerylid (Melbourne, Australia) partnered to discover anti-infective compounds. The partnership will...
...Australia) partnered to discover anti-infective compounds. The partnership will use Anadys's uHTS-ATLAS technology to screen Cerylid's...

...unwilling to build in-house, because of the complex chemical makeup of the extracts, according to Cerylid Biosciences Ltd....
...against their targets. Spun out of Amrad Corp. Ltd. (ASX:AML, Melbourne, Australia) early last year, Cerylid...
...the right of first refusal to license genes of therapeutic interest discovered by the CRC. Cerylid...

...which at least two sisters are affected by the condition. Oxagen Ltd. , Abingdon, U.K. Cerylid Biosciences Ltd....